Reviva Pharmaceuticals Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents13.4823.3718.5229.698.76
Cash & Short-Term Investments13.4823.3718.5229.698.76
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets1.210.250.40-1.591.08
Total Current Assets14.6823.7018.9231.408.76
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Other Non-Current Assets0.820.000.000.000.00
Total Non-Current Assets0.820.000.000.000.00
Total Assets15.5023.7018.9231.408.76
Current Liabilities
Accounts Payable6.283.853.520.511.01
Short-Term Debt0.460.000.000.000.00
Accrued Liabilities7.3612.375.881.840.32
Other Current Liabilities0.500.406.141.840.32
Total Current Liabilities14.6017.189.962.341.33
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.090.810.570.371.96
Total Non-Current Liabilities0.090.810.570.371.96
Total Liabilities14.6917.9810.532.723.30
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-164.27-134.35-95.09-66.83-58.31
Additional Paid-in Capital165.08140.07103.4995.5263.77
Shares Outstanding46.5827.9220.4514.430.00
Total Stockholders' Equity0.815.728.3928.695.47
Total Liabilities & Equity15.5023.7018.9231.408.76